Zacks Investment ResearchTue, 31 Mar 2026 14:36:08 GMTAcumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerABOS+3.64%
Zacks Investment ResearchMon, 30 Mar 2026 14:40:56 GMTIs Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?ABOS+3.64%
Seeking AlphaThu, 26 Mar 2026 22:25:54 GMTAcumen Pharmaceuticals, Inc. (ABOS) Q4 2025 Earnings Call TranscriptABOS+3.64%